oxazoles has been researched along with Dementia Praecox in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, J; Di Cicco, G; Fletcher, J; Grayson, B; Harte, M; Iacovelli, L; Neill, JC; Ngomba, RT; Rimmer, L; Wall, MJ | 1 |
| Aleksandrov, AA; Dmitrieva, ES; Gainetdinov, RR; Knyazeva, VM; Polyakova, NV; Volnova, AB | 1 |
| Chaki, S; Hikichi, H; Hiyoshi, T; Iida, I; Kaku, A; Karasawa, J; Marumo, T; Tamita, T; Tomishima, Y; Urabe, H; Yasuhara, A | 1 |
| Chen, B; Huang, L; Song, J; Yin, L; Zhang, W; Zhang, X | 1 |
| Balu, DT; Bolshakov, VY; Conn, PJ; Coyle, JT; Jones, CK; Li, Y; Lindsley, CW; Presti, KT; Ramikie, TS; Rook, JM; Takagi, S | 1 |
| Bergis, OE; Black, MD; Boulay, D; Defex, H; Desvignes, C; Featherstone, R; Griebel, G; Kongsamut, S; Kosley, R; Naimoli, V; Pichat, P; Potestio, L; Sahni, S; Sher, R; Slowinski, F; Varty, GB; Vigé, X | 1 |
| Bronk, BS; Bryce, DK; Coe, JW; Cook, KK; Duplantier, AJ; Evrard, E; Hajós, M; Hoffmann, WE; Hurst, RS; Maklad, N; Mather, RJ; McLean, S; Nedza, FM; O'Donnell, CJ; O'Neill, BT; Peng, L; Qian, W; Rogers, BN; Rottas, MM; Sands, SB; Schmidt, AW; Shrikhande, AV; Spracklin, DK; Wong, DF; Zhang, A; Zhang, L | 1 |
| Bradaia, A; Bruns, A; Buchy, D; Chaboz, S; Galley, G; Groebke Zbinden, K; Hoener, MC; Kilduff, TS; Metzler, V; Morairty, SR; Moreau, JL; Mory, R; Norcross, RD; Pouzet, B; Revel, FG; Risterucci, C; Tuerck, D; Wallace, TL; Wettstein, JG | 1 |
| Altmann, H; Dose, M; Emrich, HM; von Zerssen, D | 1 |
| Hanada, S; Hosomi, T; Isoda, K; Kasai, T; Kuno, T; Kuyama, T; Mita, T; Nakai, H; Nishino, N; Uchida, S | 1 |
| Frieboes, RM; Holsboer, F; Murck, H; Steiger, A; Wiedemann, K | 1 |
| Antonijevic, I; Frieboes, RM; Hinze-Selch, D; Kraus, T; Murck, H; Pollmächer, T; Steiger, A | 1 |
| Gotthardt, U; Huber, MT; Krieg, JC; Schreiber, W | 1 |
| Andreas, J; Benkert, O; Eissner, D; Gründer, G; Heydari, N; Müller, MJ; Nickel, O; Schlegel, S; Schlösser, R; Wetzel, H | 1 |
| Benkert, O; Gründer, G; Marx-Dannigkeit, P; Müller, MJ; Müller-Siecheneder, F; Wetzel, H | 1 |
| Chase, TN; Crayton, JW; Tamminga, CA | 1 |
| Chase, TN; Frohman, LA; Neophytides, A; Tamminga, CA | 1 |
| McDonald, A | 1 |
| Sharpley, P; Small, IF; Small, JG | 1 |
5 trial(s) available for oxazoles and Dementia Praecox
| Article | Year |
|---|---|
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
Topics: Adolescent; Adult; Analgesics; Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Isoxazoles; Male; Middle Aged; Mood Disorders; Oxazoles; Oxcarbazepine; Schizophrenia; Valproic Acid | 1983 |
Open clinical trial on the sigma ligand panamesine in patients with schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Female; Humans; Male; Oxazoles; Piperidines; Prolactin; Receptors, sigma; Schizophrenia; Sleep | 1997 |
Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antipsychotic Agents; Blood Cell Count; Double-Blind Method; Electroencephalography; Female; Humans; Locus Coeruleus; Male; Oxazoles; Piperidines; Receptors, sigma; Schizophrenia; Sleep; Tumor Necrosis Factor-alpha | 1999 |
Efficacy and safety of the sigma receptor ligand EMD 57445 (panamesine) in patients with schizophrenia: an open clinical trial.
Topics: Adult; Antipsychotic Agents; Female; Humans; Ligands; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, sigma; Schizophrenia; Schizophrenic Psychology | 1999 |
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Biotransformation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, sigma; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
14 other study(ies) available for oxazoles and Dementia Praecox
| Article | Year |
|---|---|
The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia.
Topics: Allosteric Regulation; Animals; Cognition; Niacinamide; Oxazoles; Phencyclidine; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Schizophrenia | 2022 |
Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice.
Topics: Amines; Animals; Antipsychotic Agents; Cognition; Evoked Potentials; Evoked Potentials, Auditory; Male; Mice; Mice, Inbred C57BL; Oxazoles; Receptors, G-Protein-Coupled; Schizophrenia; Schizophrenic Psychology; Sensory Gating | 2019 |
Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor.
Topics: Administration, Oral; Allosteric Regulation; Animals; Antipsychotic Agents; Cells, Cultured; Disease Models, Animal; Electroencephalography; Humans; Imidazoles; Male; Motor Activity; Oxazoles; Prefrontal Cortex; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Sleep, REM; Stimulation, Chemical | 2015 |
Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics.
Topics: Animals; Antipsychotic Agents; Ether-A-Go-Go Potassium Channels; Humans; Mice; Oxazoles; Patch-Clamp Techniques; Piperazines; Piperidines; Potassium Channel Blockers; Rats; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Swine | 2015 |
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.
Topics: Allosteric Regulation; Animals; Disease Models, Animal; Hippocampus; Male; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Oxazoles; Proto-Oncogene Proteins c-akt; Pyridines; Racemases and Epimerases; Receptor, Metabotropic Glutamate 5; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Signal Transduction | 2016 |
The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia.
Topics: Allosteric Site; Amphetamines; Animals; Attention; Calcium; Cerebral Cortex; Cognition; Cognition Disorders; Cyclic AMP; Dizocilpine Maleate; Electroconvulsive Therapy; HEK293 Cells; Humans; Indans; Male; Maze Learning; Memory; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxazoles; Phenotype; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Schizophrenia | 2016 |
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo eff
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Azabicyclo Compounds; Biological Availability; Cells, Cultured; Cognition Disorders; Epithelial Cells; Female; Hippocampus; Humans; Kidney; Microsomes, Liver; Nicotinic Agonists; Nootropic Agents; Oocytes; Oxazoles; Rats; Receptors, Nicotinic; Schizophrenia; Skin; Structure-Activity Relationship; Xenopus laevis | 2010 |
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Attention; Benzodiazepines; Body Weight; Cocaine; Conditioning, Operant; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Electroencephalography; Hallucinogens; Haloperidol; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Mental Recall; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microinjections; Motor Activity; Mutation; Olanzapine; Oocytes; Oxazoles; Phencyclidine; Phenethylamines; Protein Binding; Pyrrolidinones; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reinforcement, Psychology; Schizophrenia; Swimming; Telemetry; Tritium; Xenopus | 2013 |
[Increased 3H-muscimol binding in post-mortem brains of chronic schizophrenics].
Topics: Adult; Aged; Binding Sites; Chronic Disease; Female; Frontal Lobe; Glutamate Decarboxylase; Humans; Male; Middle Aged; Muscimol; Oxazoles; Putamen; Schizophrenia | 1984 |
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzamides; Blood-Brain Barrier; Corpus Striatum; Female; Humans; Male; Middle Aged; Oxazoles; Piperidines; Pyrimidines; Pyrrolidines; Receptors, Dopamine D2; Receptors, sigma; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1999 |
Improvement in tardive dyskinesia after muscimol therapy.
Topics: Adult; Aged; Antipsychotic Agents; Dopamine; Drug Evaluation; Dyskinesia, Drug-Induced; Extrapyramidal Tracts; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Muscimol; Oxazoles; Receptors, Dopamine; Schizophrenia; Stimulation, Chemical; Synaptic Transmission | 1979 |
Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
Topics: Adult; Aged; Chronic Disease; Female; gamma-Aminobutyric Acid; Growth Hormone; Humans; Huntington Disease; Kinetics; Male; Middle Aged; Muscimol; Oxazoles; Prolactin; Schizophrenia | 1978 |
Unpleasant side effects of muscimol.
Topics: Humans; Muscimol; Oxazoles; Schizophrenia | 1979 |
Influences of cylert upon memory changes with ECT.
Topics: Adult; Affective Symptoms; Central Nervous System Stimulants; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Intelligence Tests; Magnesium; Male; Memory; Oxazoles; Pemoline; Psychiatric Status Rating Scales; Psychological Tests; Schizophrenia | 1968 |